MXC Initial Director's Interest Notice Appx 3X Dr Stephen Parker 13/03/19 Share MXC European Corporate and Pharma Industry Expert Appointed NED 13/03/19 Share MXC Half Yearly Report and Accounts 28/02/19 PRICE SENSITIVE Share MXC Resignation of Joint Company Secretary 28/02/19 Share MXC Independent Validation of MXC High-Grade Cannabis Genetics 26/02/19 PRICE SENSITIVE Share MXC Change of Director's Interest Notice- Appx 3Y Roby Zomer 25/02/19 Share MXC Change of Director's Interest Notice- Appx 3Y Nativ Segev 25/02/19 Share MXC Appendix 3B - Expiry of Performance Shares 22/02/19 Share MXC Expiration of 100m Performance Shares 21/02/19 Share MXC Change of Director's Interest Notice- Appx 3Y Roby Zomer 11/02/19 Share MXC Change of Director's Interest Notice- Appx 3Y Nativ Segev 11/02/19 Share MXC Change of Director's Interest Notice- Appx 3Y Brett Mitchell 11/02/19 Share MXC MXC Botanical Update 01/02/19 PRICE SENSITIVE Share MXC Completion of MGC Derma Sale to CannaGlobal 29/01/19 PRICE SENSITIVE Share MXC Major Regulatory Milestones Achieved for Pharma Business 22/01/19 PRICE SENSITIVE Share MXC December Quarterly Activity and Cashflow Report 18/01/19 PRICE SENSITIVE Share MXC First CannEpil Product arrives in Australia 24/12/18 PRICE SENSITIVE Share MXC MXC commences trading on the US OTCQB Venture Market 19/12/18 Share MXC Release of Restricted Securities 05/12/18 Share MXC MGC Derma - CannaGlobal Transaction Update 03/12/18 PRICE SENSITIVE Share MXC Chairman's Address - 2018 AGM 22/11/18 PRICE SENSITIVE Share MXC Results of Annual General Meeting 22/11/18 Share MXC AGM 2018 Webinar Details 20/11/18 Share MXC MXC launches CannaHub with RMIT and HUJ 19/11/18 PRICE SENSITIVE Share MXC Legal Proceedings Commenced against Varm Cosmo 15/11/18 PRICE SENSITIVE Share MXC Reinstatement to Official Quotation 13/11/18 PRICE SENSITIVE Share MXC Definitive Agreement Signed for Sale of MGC Derma 13/11/18 PRICE SENSITIVE Share MXC Voluntary Suspension Extension 07/11/18 Share MXC Suspension from Official Quotation 05/11/18 PRICE SENSITIVE Share MXC Trading Halt 01/11/18 PRICE SENSITIVE Share MXC Appendix 4G and Corporate Governance Statement 31/10/18 Share MXC Annual Report 2018 31/10/18 Share MXC MXC partners with Epilepsy Action Australia 30/10/18 Share MXC September Quarterly Activity and Cashflow Report 26/10/18 PRICE SENSITIVE Share MXC Notice of Annual General Meeting/Proxy Form 22/10/18 Share MXC MGC Derma - CannaGlobal Transaction Update 19/10/18 PRICE SENSITIVE Share MXC Response to ASX Price and Volume Query 16/10/18 PRICE SENSITIVE Share MXC Trading Halt 16/10/18 PRICE SENSITIVE Share MXC Pause in Trading 16/10/18 PRICE SENSITIVE Share MXC CannEpil Authorised to Commence Australian Sales 11/10/18 PRICE SENSITIVE Share MXC Trading Halt 09/10/18 PRICE SENSITIVE Share MXC MGC Derma - CannaGlobal Transaction Update 04/10/18 PRICE SENSITIVE Share MXC Reinstatement to Official Quotation 27/09/18 PRICE SENSITIVE Share MXC Sale of MGC Derma to Strategic Partner Cannaglobal Canada 27/09/18 PRICE SENSITIVE Share MXC Suspension from Official Quotation 25/09/18 PRICE SENSITIVE Share MXC Contract Default Notice Issued To Varm Cosmo 25/09/18 PRICE SENSITIVE Share MXC Trading Halt 21/09/18 PRICE SENSITIVE Share MXC MXC Signs Major Distribution Agreement for GMP Products 06/09/18 PRICE SENSITIVE Share MXC Appendix 4E and Audited 2018 Financial Report 03/09/18 PRICE SENSITIVE Share MXC MXC to Commence Australian Dementia Trial with Notre Dame 27/08/18 PRICE SENSITIVE Share MXC Harvey Nichols Expands MGC Derma Distribution in the UK 08/08/18 PRICE SENSITIVE Share MXC Neurology & Epilepsy Expert Joins MXC Medical Advisory Board 31/07/18 Share MXC June Quarterly Activity and Cashflow Report 30/07/18 PRICE SENSITIVE Share MXC Change of Director's Interest Notice - Appendix 3Y 18/07/18 download Created with Sketch. 267.83KB Share MXC Conversion of Performance Rights - Appendix 3B & VHL Shares 18/07/18 download Created with Sketch. 977.92KB Share MXC MXC Awarded GMP Certification & Manufacturing Licence 13/07/18 PRICE SENSITIVE download Created with Sketch. 561.39KB Share MXC Trading Halt 11/07/18 PRICE SENSITIVE download Created with Sketch. 556.88KB Share MXC Harvey Nichols To Sell MGC Derma and Derma Plus Cosmetics 12/06/18 PRICE SENSITIVE download Created with Sketch. 557.22KB Share MXC Appendix 3Y - Change of Director's Interest Notice x 2 24/05/18 download Created with Sketch. 719.91KB Share MXC Maltese Government Approves Medicinal Cannabis Legislation 21/05/18 PRICE SENSITIVE Share MXC Exercise of 6.5c Listed Options - Appendix 3B 18/05/18 Share MXC Investor Presentation - May 2018 15/05/18 Share MXC Corporate Update - CEO steps into Managing Director role 15/05/18 PRICE SENSITIVE Share MXC MGC Derma launches Second Derma Plus CBD Product 10/05/18 PRICE SENSITIVE Share MXC March Quarterly Activity and Cashflow Report 30/04/18 PRICE SENSITIVE Share MXC $5m Placement Completed - Cleansing Notice & Appendix 3B 17/04/18 Share MXC Malta Govt Approval for MC Licensed Facility 12/04/18 PRICE SENSITIVE Share MXC $5m Placement at 7.0c Closed Stongly Oversubscribed 11/04/18 PRICE SENSITIVE Share MXC Contract Secured for Full MC Production Facility in Malta 11/04/18 PRICE SENSITIVE Share MXC Trading Halt 09/04/18 PRICE SENSITIVE Share MXC Production of First CannEpil Batch Commences at EU Facility 29/03/18 PRICE SENSITIVE Share MXC Appendix 3B 23/03/18 Share MXC MXC Launches MGC Nutraceuticals Product Line 13/03/18 PRICE SENSITIVE Share MXC Updated MXC Operational and Strategy Update 05/03/18 PRICE SENSITIVE Share MXC MXC Operational and Strategy Update 05/03/18 PRICE SENSITIVE Share MXC Issue of Unlisted Options - Appendix 3B 05/03/18 Share MXC Change of Registered Office 02/03/18 Share MXC Release of Shares from Escrow - Appendix 3B 02/03/18 Share MXC Half Yearly Report and Accounts 26/02/18 PRICE SENSITIVE Share MXC Exercise of 6.5c Listed Options - Appendix 3B 16/02/18 Share MXC MXC Derma Products Officially Launched on Cult Beauty Online 14/02/18 PRICE SENSITIVE Share MXC Restricted Securities to be Released from Escrow 09/02/18 Share MXC Cleansing Notice - s708A(5)(e) of the Corporations Act 2001 02/02/18 Share MXC December Quarterly Activity and Cashflow Report 31/01/18 PRICE SENSITIVE Share MXC Appendix 3Y - Change of Director's Interest Notice x 3 30/01/18 Share MXC Conversion of Performance Rights - Appendix 3B 30/01/18 Share MXC Initial GMP Certification for European Production Facility 25/01/18 PRICE SENSITIVE Share MXC Trading Halt 23/01/18 PRICE SENSITIVE Share MXC MXC Signs Exclusive Distribution Agreement with Cult Beauty 22/01/18 PRICE SENSITIVE Share MXC MXC Welcomes Federal Export Legislation 05/01/18 PRICE SENSITIVE Share MXC MGC Derma Launches CBD Herbal Psoriasis Cream 04/01/18 PRICE SENSITIVE Share MXC Response to ASX query 03/01/18 PRICE SENSITIVE Share MXC Appointment of Joint Company Secretary 02/01/18 Share MXC MXC Operational Update 18/12/17 PRICE SENSITIVE Share MXC Exercise of 6.5c Listed Options - Appendix 3B 15/12/17 Share MXC New Year Launch of MGC Derma CBD Psoriasis Cream Confirmed 14/12/17 PRICE SENSITIVE Share MXC Results of Annual General Meeting 22/11/17 Share MXC Binding Agreement to Supply $1m CBD Extract Annually 22/11/17 PRICE SENSITIVE Share MXC Definitive Supply Agreement Executed with HL Pharma 20/11/17 PRICE SENSITIVE Share MXC First Varm Cosmo Binding Purchase Order Received 14/11/17 PRICE SENSITIVE Share
